Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance

The aim of this study was to improve the understanding of the pharmacokinetic-pharmacodynamic relationships of fosfomycin against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli strains that have different fosfomycin MICs. Our methods included the use of a hollow fiber infection m...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Docobo-Pérez, F., Drusano, G. L., Johnson, A., Goodwin, J., Whalley, S., Ramos-Martín, V., Ballestero-Tellez, M., Rodriguez-Martinez, J. M., Conejo, M. C., van Guilder, M., Rodríguez-Baño, J., Pascual, A., Hope, W. W.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2015
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538498/
https://ncbi.nlm.nih.gov/pubmed/26124169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00752-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires